Review

Potential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2.

The COVID-19 virus, caused by the coronavirus SARS-CoV-2, has become a global pandemic with new strains emerging rapidly. While vaccine candidates are being rapidly developed, medicinal plant extracts show potential for developing effective antiviral nanoparticles. This systematic review focuses on the neem plant as a suitable candidate for biosynthesis of anti-SARS-CoV-2 nanoparticles. 98 studies were screened and discussed the biomedical and antiviral properties of neem extracts that could be important in the design of potential anti-SARS-CoV-2 nanoformulations.

Foka FET et al (2022).
Biomed Res Int.
PubMed:
36158879